Could direct inhibition of inflammation be the "next big thing" in treating atherosclerosis?
Pradeep
P
Natarajan
Christopher P
CP
Cannon
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000276:immunology*; D023903:Coronary Restenosis / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D018450:Disease Progression; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control*; D015607:Stents / Q000009:adverse effects
D000893:Anti-Inflammatory Agents